Christian Schade - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christian Schade since 12/24/2023

Holdings reported by Christian Schade for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 259K $954K $3.68 Jul 28, 2022 Direct
Common Stock 5K $18.4K $3.68 Jul 28, 2022 By spouse
Common Stock 1K $3.68K $3.68 Jul 28, 2022 By adult child
Stock Option (right to Buy) 47.6K Jul 28, 2022 Direct Common Stock

Transactions reported by Christian Schade for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.